If the trial is successful, the firm's complete estrogen receptor antagonist would complement its other biomarker-driven breast cancer assets.

Sanofi has agreed to purchase its own shares worth €2bn ($2.08bn), part of a $5.1bn share buyback initiative in 2025.

The manufacturer has moved to a four day working week and says it is now rebuilding market share following a challenging ...

Q4 2024 Earnings Call Transcript February 6, 2025 AstraZeneca PLC misses on earnings expectations. Reported EPS is $1.05 EPS, ...

The company plans to allocate a record amount to capital expenditures to build artificial-intelligence infrastructure.

AstraZeneca PLC (AZN) reports a robust 21% revenue increase for 2024, while navigating market challenges and strategic ...

Amazon faced ~900 Mn FX headwind in 4Q’24 which was ~700 mn higher than assumed. For the third consecutive quarter, AWS grew ...

Amazon Music and WPP unveiled Louder Than Cancer, an effort uniting top global artists to harness the power of music in recognition of World Cancer Day with creative leadership from WPP’s Grey Health, ...

A fresh earnings release was the news development powering AstraZeneca's (NASDAQ: AZN) share price higher on Thursday.

Looking ahead, Amazon forecast first-quarter revenue of between $151 billion and $155.5 billion, below the analyst consensus of $158.58 billion. Amazon said the forecast reflects "an unusually large, ...

The Amazon company's revenue was just over the expectations, but its earnings-per-share were a substantial win.